carbostyril has been researched along with Pneumonia in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 22 (44.90) | 18.2507 |
| 2000's | 8 (16.33) | 29.6817 |
| 2010's | 12 (24.49) | 24.3611 |
| 2020's | 6 (12.24) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, Z; Pan, X; Tang, W; Yin, Y; Zhao, M | 1 |
| Liang, J; Liu, Y; Lv, Y; Niu, H; Xia, X; Yuan, X; Zhang, A; Zhang, D | 1 |
| Neeland, MR; Ranganathan, S; Shanthikumar, S | 1 |
| Chang, LW; Hsueh, PR; Jean, SS | 1 |
| Cheng, SH; Hsu, YJ; Huang, YL; Lai, JH; Lin, CW; Liou, JT; Pan, HY; Tsai, CL; Wang, MT | 1 |
| Harwood, KH; Jarnicki, A; McQuade, RM; Schneider-Futschik, EK | 1 |
| Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T | 1 |
| Akashi, Y; Hayashi, D; Imai, H; Ishikawa, H; Ishiodori, T; Kanemoto, K; Notake, S; Shiigai, M; Suzuki, H | 1 |
| Chang, LW; Chang, YT; Cheng, SL; Chuang, YC; Hsu, MC; Perng, WC; Tsao, SM; Wu, RG | 1 |
| Fukuda, Y; Fukushima, K; Hashiguchi, K; Higashiyama, Y; Imamura, Y; Inoue, Y; Izumikawa, K; Kobayashi, T; Koga, H; Kohno, S; Kondo, A; Mikushi, S; Miyazaki, T; Morinaga, Y; Mukae, H; Nagayoshi, Y; Nakamura, S; Saijo, T; Sasaki, E; Takazono, T; Yamamoto, K; Yanagihara, K; Yoshida, M | 1 |
| Boersma, WG; Bonten, MJ; Buijs, J; Buunk, G; Compaijen, CJ; Gisolf, JE; Huijts, SM; Kluytmans, JA; Kuipers, BA; Mager, JJ; Oppedijk, B; Palmen, F; Prins, JM; Silbermann, MH; van der Kam, R; van der Wall, E; van der Werf, TS; van Elde, LJ; van Reemst, B; van Tiel, FH; van Werkhoven, CH | 1 |
| Huang, H; Qin, X | 1 |
| Poole, RM | 1 |
| Bester, AJ; Chang, LW; Chang, YT; Chung, DT; Ho, ML; Hsu, MC; Kasumba, J; King, CH; Mitha, IH; Perng, RP; van Rensburg, DJ; Wu, RG | 1 |
| Gonzales, R; Hersh, AL | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; López-Rojas, R; Pachón, J; Sánchez-Céspedes, J; Vila, J | 1 |
| Chen, LA; Falagas, ME; Liu, YN; Matthew, FE; Wang, R; Zhang, L | 1 |
| Ala-Kokko, TI; Karhu, J; Ohtonen, P; Syrjälä, H | 1 |
| Frothingham, R | 1 |
| Bilbao, A; Capelastegui, A; España, PP; Gallardo, MS; Gorordo, I; Idoiaga, I; Quintana, JM | 1 |
| Niederman, MS | 1 |
| Carlet, J | 1 |
| Chang, KC; Leung, CC | 1 |
| Matuschka, PR; Vissing, RS | 1 |
| Imada, T; Mukai, F; Ohguro, K; Ohmori, K; Tamaoka, H; Wakebe, H; Yabuuchi, Y; Yoneda, H | 1 |
| Aoun, M; Bourguignon, AM; Daneau, D; Janssen, M; Meunier, F; Van der Auwera, P; Varthalitis, I | 1 |
| Iwagaki, A; Matsumoto, K; Nagatake, T; Oishi, K; Pollack, M; Ponglertnapagorn, P; Siadak, A; Sonoda, F; Watanabe, K | 1 |
| Apley, MD; Upson, DW | 2 |
| Ootaki, M; Suzuki, Y; Tabeta, H | 1 |
| Ambrose, PG; Nightingale, CH; Owens, RC; Quintiliani, R | 1 |
| Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL | 1 |
| Fraser, KL; Grossman, RF | 1 |
| Friis, HM | 1 |
| Lexchin, J | 1 |
| Arakawa, M; Fujimori, K; Gejyo, F; Mochizuki, H; Suzuki, E | 1 |
| Carbon, C; Chauvin, JP; Hazebroucq, J; Léophonte, P; Petitpretz, P | 1 |
| Iwagaki, A; Kobayashi, S; Matsumoto, K; Nagatake, T; Oishi, K; Sonoda, F | 1 |
| Boone, G; Cornelis, C; van Schoubroek, L | 1 |
| Chodosh, S | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Pocidalo, JJ; Vallée, E | 1 |
| Kosmidis, J | 1 |
| Lode, H; Vogel, F | 1 |
| Art, T; Lekeux, P | 1 |
9 review(s) available for carbostyril and Pneumonia
| Article | Year |
|---|---|
Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.
Topics: Aminophenols; Aminopyridines; Anti-Inflammatory Agents; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Indoles; Inflammation; Ion Transport; Lung; Macrophages; Pneumonia; Quinolones; Signal Transduction | 2021 |
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Drug Therapy, Combination; Female; Guideline Adherence; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Netherlands; Pneumonia; Quinolones; Radiography, Thoracic; Severity of Illness Index; Treatment Outcome | 2013 |
Review of nemonoxacin with special focus on clinical development.
Topics: Animals; Clinical Trials as Topic; Community-Acquired Infections; Humans; Pneumonia; Quinolones | 2014 |
Nemonoxacin: first global approval.
Topics: Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Drug Approval; Humans; Pneumonia; Quinolones | 2014 |
Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Community-Acquired Infections; Fluoroquinolones; Gemifloxacin; Humans; Naphthyridines; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin.
Topics: Aza Compounds; Community-Acquired Infections; Disease Management; Drug Resistance, Microbial; Fluoroquinolones; Humans; Infusions, Intravenous; Moxifloxacin; Pneumonia; Quinolines; Quinolones; Streptococcus pneumoniae; Treatment Outcome | 2005 |
New generations of quinolones: with particular attention to levofloxacin.
Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones | 1997 |
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections | 1998 |
What new antibiotics to offer in the outpatient setting.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans; Macrolides; Pneumonia; Quinolones | 1998 |
9 trial(s) available for carbostyril and Pneumonia
| Article | Year |
|---|---|
Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Community-Acquired Infections; Double-Blind Method; Drug Combinations; Female; Fluoroquinolones; Humans; Levofloxacin; Lung Diseases; Male; Middle Aged; Pneumonia; Quinolones; Safety; South Africa; Taiwan; Treatment Outcome; Young Adult | 2019 |
The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Japan; Male; Pneumonia; Quinolones | 2019 |
Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia.
Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Quinolones; Treatment Outcome | 2010 |
Clinafloxacin-theophylline drug interaction.
Topics: Aged; Anti-Infective Agents; Cross Infection; Delayed-Action Preparations; Drug Interactions; Drug Monitoring; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Pneumonia; Quinolones; Theophylline | 1995 |
A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bacteremia; Drug Resistance, Microbial; Drug Tolerance; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Pefloxacin; Pneumonia; Prospective Studies; Quinolones; Staphylococcal Infections; Teicoplanin | 1994 |
Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteria; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia; Quinolones | 1992 |
Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
Topics: Ambulatory Care; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Quinolones; Respiratory Tract Infections | 1991 |
A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
Topics: Adolescent; Adult; Anti-Infective Agents; Bronchitis; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Pneumonia; Quinolones; Respiratory Tract Infections | 1991 |
The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cefotaxime; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Quinolones | 1991 |
31 other study(ies) available for carbostyril and Pneumonia
| Article | Year |
|---|---|
Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cost-Benefit Analysis; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Tuberculosis, Pulmonary | 2022 |
Clinical characteristics of 14 cases of severe Chlamydia psittaci pneumonia diagnosed by metagenomic next-generation sequencing: A case series.
Topics: Chlamydophila psittaci; Creatine Kinase; Doxycycline; Female; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Pneumonia; Procalcitonin; Psittacosis; Quinolones; Retrospective Studies | 2022 |
Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Mutation; Pneumonia; Quinolones | 2022 |
Tentative clinical breakpoints and epidemiological cut-off values of nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates associated with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Humans; Pneumonia; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae | 2020 |
Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Beclomethasone; Benzyl Alcohols; Budesonide, Formoterol Fumarate Drug Combination; Chlorobenzenes; Cohort Studies; Comparative Effectiveness Research; Disease Progression; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Glycopyrrolate; Humans; Indans; Male; Muscarinic Antagonists; Pneumonia; Propensity Score; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines | 2021 |
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric | 2017 |
Implementation of Point-of-Care Molecular Diagnostics for Mycoplasma pneumoniae Ensures the Correct Antimicrobial Prescription for Pediatric Pneumonia Patients.
Topics: Adolescent; Anti-Bacterial Agents; Child; Drug Prescriptions; Female; Humans; Macrolides; Male; Mycoplasma pneumoniae; Pathology, Molecular; Pneumonia; Point-of-Care Systems; Quinolones; Tetracycline; Time Factors | 2018 |
Decreasing out-of-pocket costs of antibiotics: the good, the bad, and the unknown.
Topics: Administration, Oral; Ambulatory Care; Anti-Bacterial Agents; Drug Costs; Drug Prescriptions; Humans; Insurance Coverage; Macrolides; Medicare Part D; Odds Ratio; Pneumonia; Practice Patterns, Physicians'; Quinolones; Research Design; United States | 2010 |
Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Lethal Dose 50; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Conformation; Pneumonia; Quinolones | 2011 |
Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Macrolides; Male; Middle Aged; Pneumonia; Quinolones; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2013 |
Addition of quinolones to hospital formularies changes pneumonia treatment.
Topics: Formularies, Hospital as Topic; Humans; Pneumonia; Quinolones; United States | 2003 |
Quinolone safety and efficacy more important than potency.
Topics: Adult; Bacterial Infections; Community-Acquired Infections; Dose-Response Relationship, Drug; Female; Humans; Pneumonia; Quinolones | 2004 |
Management of community-acquired pneumonia and secular trends at different hospitals.
Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; Critical Care; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pneumonia; Quinolones; Retrospective Studies; Severity of Illness Index | 2005 |
[Comments on the XV(e) consensus conference: "Managing low tract respiratory infections in the immunocompetent adult"].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Consensus Development Conferences as Topic; Disease Management; Drug Therapy, Combination; Humans; Immunocompetence; Pneumonia; Practice Guidelines as Topic; Quinolones | 2007 |
[Antibiotic therapy in pneumonia. Cave resistance and pneumococcal loopholes].
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Resistance, Bacterial; Hospitalization; Humans; Macrolides; Penicillins; Pneumonia; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Quinolones; Radiography; Risk Factors; Streptococcus pneumoniae | 2007 |
Meta-analysis may not be practicable for guiding antibiotic therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis, Chronic; Drug Therapy; Humans; Macrolides; Meta-Analysis as Topic; Pneumonia; Practice Patterns, Physicians'; Quinolones | 2008 |
Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Piperazines; Pneumonia; Quinolones; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections | 1994 |
Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Infective Agents; Antibodies, Monoclonal; Bacteremia; Cell Movement; Female; Flagella; Fluoroquinolones; Humans; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Opsonin Proteins; Phagocytosis; Pneumonia; Pseudomonas Infections; Quinolones; Serotyping | 1993 |
Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia.
Topics: Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Fluoroquinolones; Injections, Intramuscular; Injections, Intravenous; Lung; Male; Pneumonia; Quinolones | 1993 |
Regional danofloxacin lung tissue concentrations and their relationship to regional pulmonary blood flow in consolidated and nonconsolidated bovine lung.
Topics: Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Fluoroquinolones; Lung; Pneumonia; Pulmonary Circulation; Quinolones | 1993 |
[Bilateral meningococcal pneumonia in a young Japanese woman].
Topics: Adult; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Meningococcal Infections; Pneumonia; Quinolones | 1996 |
Sparfloxacin and levofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones | 1997 |
Grepafloxacin--a new fluoroquinolone.
Topics: Administration, Oral; Anti-Infective Agents; Chlamydophila pneumoniae; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Fluoroquinolones; Haemophilus; Half-Life; Humans; Legionella pneumophila; Moraxella catarrhalis; Mycoplasma pneumoniae; Piperazines; Pneumonia; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae | 1998 |
New antibiotic approved for community-acquired infections.
Topics: Anti-Infective Agents; Bronchitis; Community-Acquired Infections; Contraindications; Fluoroquinolones; Humans; Piperazines; Pneumonia; Quinolones; Sexually Transmitted Diseases; United States; United States Food and Drug Administration | 1998 |
[Grepafloxacin (Raxar)].
Topics: Anti-Infective Agents; Bronchitis; Contraindications; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Pneumonia; Quinolones; Urethritis; Uterine Cervicitis | 1998 |
Drug not considered a first-line agent.
Topics: Anti-Infective Agents; Community-Acquired Infections; Drug Prescriptions; Drug Resistance, Microbial; Fluoroquinolones; Humans; Piperazines; Pneumonia; Practice Guidelines as Topic; Quinolones | 1998 |
[A case of rebamipide-induced pneumonitis].
Topics: Aged; Alanine; Anti-Ulcer Agents; Humans; Male; Pneumonia; Quinolones | 2002 |
Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Antibodies, Monoclonal; Cyclophosphamide; Drug Therapy, Combination; Female; Fluoroquinolones; Immunoglobulin G; Injections, Intravenous; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Pneumonia; Pseudomonas Infections; Quinolones | 1992 |
[Comparative clinical study of 2 antibiotic injectable preparations in the treatment of airway infections in veal calves].
Topics: Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Enrofloxacin; Fluoroquinolones; Neomycin; Penicillin G Procaine; Pneumonia; Quinolones | 1992 |
Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin.
Topics: Acute Disease; Animals; Anti-Infective Agents; Disease Models, Animal; Female; Fluoroquinolones; Mice; Mice, Inbred Strains; Ofloxacin; Pneumonia; Quinolones; Streptococcus pneumoniae | 1991 |
Effect of enrofloxacin therapy on shipping fever pneumonia in feedlot cattle.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Blood Gas Analysis; Body Weight; Cattle; Enrofloxacin; Fluoroquinolones; Injections, Intramuscular; Male; Pasteurella Infections; Pasteurellosis, Pneumonic; Pneumonia; Quinolones | 1988 |